Bionano Genomics (BNGO) to Release Earnings on Tuesday

Bionano Genomics (NASDAQ:BNGO) is projected to announce its earnings results before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings of ($8.40) per share and revenue of $6.20 million for the quarter.

Bionano Genomics Price Performance

NASDAQ:BNGO opened at $4.96 on Tuesday. The business has a 50 day simple moving average of $9.91 and a 200-day simple moving average of $17.55. Bionano Genomics has a 1 year low of $4.75 and a 1 year high of $81.00. The firm has a market capitalization of $9.69 million, a price-to-earnings ratio of -0.04 and a beta of 2.14. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.99.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut shares of Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Friday, November 15th.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.